Anondita Medicare Ltd: Stock Analysis & Fundamentals

Updated this week

Anondita Medicare Ltd (Contraceptives/Protectives) — fundamental analysis, earnings data, and key metrics. PE: 55.5. ROE: 41.7%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

📊Debt increased 74% YoY — leverage rising

Key Numbers

Current Price

₹704

Market Cap

1.3K Cr

Valuation

N/A

← Back to Contraceptives/Protectives Dashboard

Frequently Asked Questions: Anondita Medicare Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Anondita Medicare Ltd's latest quarterly results?

Anondita Medicare Ltd's latest quarterly results (Sep 2025) show

PAT Growth YoY: +116.7%
Revenue Growth YoY: +74.2%
Operating Margin: 35.0%

What is Anondita Medicare Ltd's current PE ratio?

Anondita Medicare Ltd's current PE ratio is 55.5x.

Current PE: 55.5x
Market Cap: 1.3K Cr

What is Anondita Medicare Ltd's price-to-book ratio?

Anondita Medicare Ltd's price-to-book ratio is 11.7x.

Price-to-Book (P/B): 11.7x
Book Value per Share: ₹60
Current Price: ₹704

Is Anondita Medicare Ltd a fundamentally strong company?

Anondita Medicare Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 62.0%

Is Anondita Medicare Ltd debt free?

Anondita Medicare Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹47 Cr

Is Anondita Medicare Ltd's cash flow positive?

Anondita Medicare Ltd's operating cash flow is negative (FY2025).

Cash from Operations (CFO): ₹-10 Cr
Free Cash Flow (FCF): ₹-33 Cr
CFO/PAT Ratio: -62% (weak cash conversion)

What is Anondita Medicare Ltd's dividend yield?

Anondita Medicare Ltd currently does not pay a significant dividend (yield 0.00%).

Dividend Yield: 0.00%
Current Price: ₹704

Who holds Anondita Medicare Ltd shares — promoters, FII, DII?

Anondita Medicare Ltd's shareholding pattern (Sep 2025)

Promoters: 61.8%
FII (Foreign): 4.2%
DII (Domestic): 6.5%
Public: 27.4%

Is Anondita Medicare Ltd a new momentum entry or an established outperformer?

Anondita Medicare Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Anondita Medicare Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Anondita Medicare Ltd may be worth studying

Currently showing mixed signals — monitor for clearer trend confirmation

What is the investment thesis for Anondita Medicare Ltd?

Anondita Medicare Ltd investment thesis summary:

What is the future outlook for Anondita Medicare Ltd?

Anondita Medicare Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.